Cellectis (CLLS) Invested Capital (2015 - 2026)
Cellectis (CLLS) posted quarterly Invested Capital of $8.9 million for Q1 2026, down 46.96% year-over-year from $16.8 million in Q1 2025, and down 92.2% quarter-over-quarter from $114.1 million in Q4 2025.
Cellectis (CLLS) Invested Capital (2015 - 2026) Analysis & Trends
Cellectis' Invested Capital history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Invested Capital fell 46.96% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $229.4 million (up 38.45% YoY), while the FY2025 annual figure was $114.1 million, down 17.57% from the prior year.
- Invested Capital for Q1 2026 stood at $8.9 million, down from $114.1 million in the prior quarter.
- The five-year high for Invested Capital was $138.4 million in Q4 2024, with the low at $5.1 million in Q3 2023.
- The 5-year median for Invested Capital is $11.3 million (2022), against an average of $38.8 million.
- The sharpest annual moves came in 2023 and 2025: Invested Capital sank 58.85% in 2023, then jumped 1621.43% in 2025.
- Cellectis' Invested Capital stood at $117.5 million in 2022, then fell by 21.63% to $92.1 million in 2023, then soared by 50.32% to $138.4 million in 2024, then retreated by 17.57% to $114.1 million in 2025, then plunged by 92.2% to $8.9 million in 2026.
- Business Quant data shows CLLS's Invested Capital at $8.9 million in Q1 2026, $114.1 million in Q4 2025, and $18.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | 8.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.90 Mn |
| Dec 31, 2025 | 114.09 Mn |
| Sep 30, 2025 | 18.24 Mn |
| Jun 30, 2025 | 88.12 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 138.41 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 92.07 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 117.48 Mn |
| Sep 30, 2022 | 10.38 Mn |
| Jun 30, 2022 | 11.31 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 139.73 Mn |
| Dec 31, 2020 | 155.03 Mn |
| Jun 30, 2020 | 3.78 Mn |